Efficacy and Safety of Upadacitinib in a Case of Pediatric Acute Severe Ulcerative Colitis and Immune Thrombocytopenia. [PDF]
Bocchini B +6 more
europepmc +1 more source
JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology. [PDF]
Foggi G +7 more
europepmc +1 more source
Upadacitinib successfully treats Hailey-Hailey disease: a cases report and literature review. [PDF]
Wu Z, Zhu Q, Yang X, Xie X, Zhang G.
europepmc +1 more source
Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis [PDF]
Adult atopic dermatitis (AD), specifically late-onset phe- notypes, is characterized by a notable degree of clinical heterogeneity in terms of morphologic and topographic characteristics.
Andrea Chiricozzi +15 more
core
Rapid Induction of Remission With Upadacitinib Followed by Cytomegalovirus Colitis in a Hospitalized Patient With Crohn's Disease. [PDF]
Herran R +14 more
europepmc +1 more source
Fatal Suicide Attempt with Upadacitinib (Rinvoq<sup>®</sup>) in an Adolescent: A Case Report. [PDF]
Stoykova S +3 more
europepmc +1 more source
Treatments for actinic prurigo: A case report with upadacitinib and systematic review. [PDF]
Perlmutter JW, Levy R, Sibbald C.
europepmc +1 more source
Benefit-risk profile of upadacitinib: exploratory post hoc analysis of phase 2b/3 studies in patients with moderately to severely active ulcerative colitis or Crohn's disease. [PDF]
Vermeire S +18 more
europepmc +1 more source
Upadacitinib versus Tofacitinib in the Management of Ulcerative Colitis: A Systematic Review and Meta-Analysis. [PDF]
Alsaleh T +7 more
europepmc +1 more source
JAK-1 inhibitors in the management of atopic dermatitis in patients over 65 years old: a descriptive cohort study. [PDF]
Zheng J +6 more
europepmc +1 more source

